Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
98 Cards in this Set
- Front
- Back
name Parkinson's drugs
|
BROMOCRIPTINE, AMANTADINE, LEVODOPA (w/carbidopa), SELEGILINE (and COMT inhibitors), antimuscarinics (eg BENZOTROPINE)
|
|
what parkinson drugs act to increase DA levels?
|
L-dopa/carbidopa, amantidine
|
|
why is L-dopa paired with carbidopa?
|
tho L-dopa crosses BBB, a large % will be decarboxylated to DA in periph, so it is paired w/carbidopa, a DA decarboxylase inhib that does not cross the BBB
|
|
toxicity of L-dopa?
|
arrhythmias from periph conversion to DA; long term use can cause dyskinesia after admin, and akinesia b/t doses (="on-off phenomenon")
|
|
what parkinson drugs act to agonize DA receptors?
|
BROMOCRIPTINE, PRAMIPEXOLE, ROPINIROLE
|
|
MoA of BROMOCRIPTINE?
|
D2 agonist and D1 antagonist
|
|
Clinical uses of BROMOCRIPTINE?
|
parkinson's, **hyperprolactinemia**, suppression of lactation in non-nursing moms, acromegaly (mediated by D1 antag, b/c DA increases GH s/c)
|
|
what class is BROMOCRIPTINE in?
|
ergot alkaloid
|
|
what parkinson drugs act to prevent DA breakdown?
|
SELEGILINE (MAO-B inhib); ENTACAPONE, TOLCAPONE (COMT inhibitors)
|
|
what drug is SELEGILINE usu paired with?
|
is used as adjunctive agent w/ L-dopa, but may also enhance adverse effects of L-dopa
|
|
what parkinson drugs act to curb excess cholinergic activity?
|
antimuscarinics, eg BENZTROPINE
|
|
BENZTROPINE has the greatest effect on which parkinson's sx?
|
tremor, rigidity; but little effect on bradykinesia
|
|
MoA of SUMATRIPTAN?
|
5HT1D agonist, causes vasoconstriction
|
|
clinical uses of SUMATRIPTAN?
|
acute migraine, cluster headache attacks
|
|
toxicity of SUMATRIPTAN? contraindications?
|
coronary vasospasm, mild tingling; contraind in pts with CAD or prinzmetal's angina
|
|
toxicity of BENZODIAZEPINES?
|
sedation, tolerance, dependence, additive CNS depress w/etoh (less risk of cardioresp dep/coma than barbs)
|
|
toxicity of CARBAMAZEPINE?
|
diplopia, ataxia, blood dyscrasias (agranulocytosis, aplastic anemia), liver tox, teratogenesis, induction of P450
|
|
toxicity of ETHOSUXIMIDE?
|
GI distress, lethargy, headache, urticaria, Stevens-Johnson syndrome
|
|
toxicity of PHENOBARBITAL?
|
sedation, tolerance, dependence, induction of P450 (thus many drug interactions), cardioresp depress (->death), additive CNS depress w/etoh
|
|
toxicity of PHENYTOIN?
|
nystagmus, diplopia, ataxia, sedation, SLE-like syndrome, induction of P450; w/chronic use: gingival hyperplasia in kids, periph neuropathy, hirsutism, megaloblastic anemia (dec folate absor), malig hypertherm (rare); teratogenic (fetal hydantoin synd)
|
|
toxicity of VALPROIC ACID?
|
GI distress, rare but fatal hepatotoxicity (measure LFTs), neural tube defects in fetus (spina bifida), tremor, weight gain
|
|
toxicity of LAMOTRIGINE?
|
Steven-Johnson synd
|
|
toxicity of GABAPENTIN?
|
sedation, ataxia
|
|
toxicity of TOPIRAMATE?
|
sedation, mental dulling, kidney stones, weight loss
|
|
MoA of PHENYTOIN?
|
use dependent blockade of Na channels (binds when in inactivated state and prolongs refrac period), inhib' glutamate release from excitatory presyn neurons
|
|
clinical uses of PHENYTOIN?
|
first line tonic clonic, first line status epilepticus prophylaxis, also used for partial seizures; also used as class IB antiarrhythmic
|
|
MoA of CARBAMAZEPINE?
|
use dependent blockade of Na channels (binds when in inactivated state and prolongs refrac period)
|
|
clinical uses of CARBAMAZEPINE?
|
1st line tonic clonic
1st line trigeminal neuralgia good for partial seiz 2nd line bipolar d/o |
|
MoA of LAMOTRIGINE?
|
blocks voltage-gated Na channels
|
|
clinical uses of LAMOTRIGINE?
|
partial, tonic clonic
|
|
MoA of GABAPENTIN?
|
increases GABA release
|
|
clinical uses of GABAPENTIN?
|
partial, tonic clonic, peripheral neuropathies (neuropathic pain syndromes)
|
|
MoA of TOPIRAMATE?
|
inactivates Na channels (same as phenytoin, carbamazapine); potentiates GABA-ergic transmiss; blocks glutamate at AMPA/kainate receptors
|
|
clinical uses of TOPIRAMATE?
|
partial, tonic clonic
|
|
MoA of PHENOBARBITAL?
|
inc GABA-A action by inc DURATION of Cl channel opening, thus dec neuronal firing
|
|
can barbituates alone be lethal?
|
yes; b/c at high doses, barbs can directly activate GABA channel
|
|
clinical uses of PHENOBARBITAL?
|
partial, tonic clonic
1st line in pregnant women, kids |
|
contraindic of BARBITUATES?
|
**porphyria**
|
|
tx of BARBITUATE o.d.?
|
sx management (assist respirations, inc BP, etc)
|
|
MoA of VALPROIC ACID?
|
inc GABA accumulation, inc Na channel inactivation
|
|
clinical uses of VALPROIC ACID?
|
1st line myoclonic, tonic clonic
partial absence (2nd line unless pt has other seizures too) mood stabilizer in mania |
|
MoA of ETHOSUXIMIDE?
|
blocks low-threshold T-type Ca channels (provide pacemaker current in thalamic neurons)
|
|
clinical uses of ETHOSUXIMIDE?
|
1st line absence seizures
|
|
MoA of BENZODIAZEPINES?
|
enhance GABA-A by inc FREQUENCY of Cl channel opening
|
|
Clinical uses of BENZOS?
|
anxiety, spasticity, detox (esp etoh), night terrors, sleepwalking, 1st line status epilepticus (lorazepam and diazepam)--also used to prevent seizures of eclampsia
|
|
Tx for BENZO O.D.?
|
FLUMAZENIL (competitive agonist at GABA receptor)
|
|
name BENZOS
|
DIAZEPAM, LORAZEPAM, TRIAZOLAM, TEMAZEPAM, OXAZEPAM, MIDAZOLAM, CHLORDIAZEPOXIDE, ALPRAZOLAM
|
|
short acting BENZOS?
|
TRIAZOLAM, OXAZEPAM, MIDAZOLAM
(TOM thumb) |
|
name inhaled anesthetics
|
HALOTHANE, ENFLURANE, ISOFLURANE, SEVOFLURANE, METHOXYFLURANE, NITROUS OXIDE
|
|
how does potency of inhaled anesthetics relate to lipid solubility?
|
potency is directly proportional to lipid solubility
|
|
clinical effects of inhaled anesthetics?
|
myocard dep, resp dep, naus/emesis, inc cerebral blood flow (dec cerebral metabolic demand)
|
|
SE/toxicity of inhaled anesthetics?
|
malig hyperthermia (w/gen predisp, causes massive release of Ca stores, tonic musc contrac); hepatotox (HALOTHANE); nephrotox (METHOXYFLURANE); proconvulsant (ENFLURANE)
|
|
what is the solubility and potency of NITROUS OXIDE? how does this impact is usage?
|
used in conjunction w/others b/c can't produce complete anesth alone; low blood and lipid solubility, thus fast induction and low potency, which permits close regulation of the level of anesth; is also least likely to dec BP or inc pCO2
|
|
classes of IV anesthetics?
|
barbituates, benzos, ketamine (arylcylcohexamines), opiates, propofol
|
|
name BARBITUATES
|
PHENOBARBITAL, PENTOBARBITAL, THIOPENTAL, SECOBARBITAL
|
|
time of onset on THIOPENTAL?
|
unconsciousness 15-30sec after admin
|
|
what characteristics are responsible for fast onset/short duration of THIOPENTAL?
|
high pot, high lipid solubility (crosses BBB fast, but also has fast redistribution to other organs)
|
|
clinical uses of THIOPENTAL?
|
induction of anesth in combo w/inhaled anesth', often in short surgical procedures
|
|
effect of THIOPENTAL on cerebral blood flow?
|
it decreases cerebral blood flow and O2 consumption by brain
|
|
what drug is most commonly used for endoscopy?
|
MIDAZOLAM
|
|
clinical indications for BENZOS
|
pre-op sedation, intra-op sedation (if analgesia not required), in combo w/other agents
|
|
why is MIDAZOLAM a good pre-op agent?
|
it produces antegrade amnesia (loss of mem after admin of drug), which calms pt
|
|
what type of anesthesia does KETAMINE produce?
|
dissociative anesthesia (=catatonia, amnesia, analgesia w/o loss of consc)
|
|
clinical indications of KETAMINE
|
trauma cases where CV support needed; in kids during painful procedures, to facilitate pt coop
|
|
CV effects of KETAMINE?
|
stim' sympathetic NS -> CV stim (inc HR, art BP, CO)
|
|
effects of KETAMINE on cerebral blood flow?
|
INC' cerebral blood flow (thus is NOT used in head trauma cases)
|
|
SEs of KETAMINE?
|
halluc, bad dreams, disorientation
|
|
name opioids used as IV anesthetics
|
MORPHINE, FENTANYL
|
|
MoA of MORPHINE
|
binds mu-opioid recep -> dec NT release from presyn nocioceptive neurons, and hyperpol' and inhib' postsyn neurons
|
|
clinical uses of MORPHINE?
|
severe pain, acute pulm edema (venodil->dec preload->dec perception of SOB)
|
|
SEs of MORPHINE?
|
dependence, w/drawl, O.D., constipation (dec motility), biliary colic (inc sphincter of Oddi tone), naus/vom
|
|
sx of OPIOID withdrawal?
|
lacrimation, rhinorrhea, sweating, gooseflesh, nausea, tachypnea
|
|
sx of OPIOID O.D.?
|
coma, pinpoint pupils, resp dep
|
|
tx for OPIOID O.D.?
|
NALOXONE (=pure antag at opioid mu recep)
|
|
uses of PROPOFOL?
|
rapid anesth induction and short procedures (similar pharm-dynam as thiopental, but w/less postop nausea)
|
|
what are the 2 types of local anesthetics?
|
ester and amide anesthetics
|
|
name ester anesthetics
|
PROCAINE, COCAINE, TETRACAINE
|
|
name amide anesthetics
|
LIDOCAINE, MEPIVACAINE, BUPIVACAINE
|
|
MoA of local anesthetics?
|
block Na channels by binding on inside of membrane, thus block nerve conduc
|
|
how does charge affect mech/binding of local anesthetics?
|
tert amine local anesth' penetrate memb in uncharged form, bind as charged form
|
|
what dosing adjustments must be made for local anesthetics when used on infected (acidic) tissue?
|
must use more, b/c in acidic envir anesth' are charged and can't penetrate membrane effectively
|
|
what is the order of nerve blockade by local anesthetics?
|
rapidly firing>slowly; smaller>larger; myelinated>unmyel (less impt)
ex. very small unmyel pain fiber>small myel ANS fiber>large myel ANS fiber |
|
order of sensation loss with local anesthesia?
|
pain>temp>touch>pressure
|
|
what type of drug are local anesthetics commonly paired with? why?
|
vasoconstrictors (alpha-1 agonist, eg. epi)-> enhance local action, inc duration of action (limits removal/metab of drug), dec bleeding
|
|
clinical uses of local anesthetics?
|
minor surg procedures, spinal anesthesia
|
|
toxicity of local anesthetics?
|
CNS excitation (restlessness, paresthesias, tinnitus, convulsions); myocard dep and hypotens, except cocaine, which causes vasocons and hypertens
|
|
clinical uses of neuromuscular blocking drugs
|
musc paralysis in surg or mechanical ventilation
|
|
name depolarizing neuromusc blockers
|
SUCCINYLCHOLINE
|
|
MoA of SUCCINYLCHOLINE?
|
PHASE 1 (prolonged depol): binds motor nicotinic recep, opens Na chan, memb depol, transient fasic'->flaccid paralysis
PHASE 2 (repolarized but blocked): memb partially repol', but is desens'd to ACh, preventing further APs |
|
Is there an antidote to SUCCINYLCHOLINE during PHASE 1 blockade?
|
no
|
|
what happens if give cholinesterase inhibitor during PHASE 1 SUCCINYLCHOLINE blockade?
|
the block is potentiated by AChE inhib
|
|
is there an antidote to PHASE 2 SUCCINYLCHOLINE blockade?
|
yes: AChE inhib (eg neostigmine)
|
|
name nondepolarizing neuromuscular blocking drugs
|
TUBOCURARINE, ATRACURIUM, MIVACURIUM, PANCURONIUM, VECURONIUM, RAPACURONIUM
|
|
MoA of nondepol neuromusc blockers?
|
competitively block chol transmiss at nic recep by preventing ACh from binding to receptor
|
|
can nondepol neuromusc block be reversed?
|
yes: AChE inhibitors (eg neostigmine, edrophonium, etc)
|
|
concomittant admin of what two drugs causes malignant hyperthermia?
|
inhalation anesthetics (except N2O) and succinylcholine
|
|
clinical uses of DANTROLENE?
|
tx of malignant hyperthermia, and neuroleptic malignant syndrome
|
|
MoA of DANTROLENE?
|
prevents release of Ca from sarco retic of skel musc
|